Verde Bio Holdings Stock Total Asset
Verde Bio Holdings fundamentals help investors to digest information that contributes to Verde Bio's financial success or failures. It also enables traders to predict the movement of Verde Pink Sheet. The fundamental analysis module provides a way to measure Verde Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Verde Bio pink sheet.
Verde |
Verde Bio Holdings Company Total Asset Analysis
Verde Bio's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Verde Bio Total Asset | 5.09 M |
Most of Verde Bio's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Verde Bio Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Verde Bio Holdings has a Total Asset of 5.09 M. This is 99.99% lower than that of the Energy sector and 99.98% lower than that of the Oil & Gas E&P industry. The total asset for all United States stocks is 99.98% higher than that of the company.
Verde Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Verde Bio's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Verde Bio could also be used in its relative valuation, which is a method of valuing Verde Bio by comparing valuation metrics of similar companies.Verde Bio is currently under evaluation in total asset category among its peers.
Verde Fundamentals
| Return On Equity | -0.53 | |||
| Return On Asset | -0.39 | |||
| Profit Margin | (1.79) % | |||
| Operating Margin | (2.60) % | |||
| Current Valuation | 2.42 M | |||
| Shares Outstanding | 1.35 B | |||
| Shares Owned By Insiders | 2.00 % | |||
| Price To Book | 0.70 X | |||
| Price To Sales | 2.55 X | |||
| Revenue | 720 K | |||
| Gross Profit | 635.38 K | |||
| EBITDA | (2.79 M) | |||
| Net Income | (3.42 M) | |||
| Cash And Equivalents | 101.11 K | |||
| Total Debt | 265.14 K | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 0.15 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (1.15 M) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 2.88 | |||
| Market Capitalization | 1.55 M | |||
| Total Asset | 5.09 M | |||
| Z Score | 3.0 | |||
| Net Asset | 5.09 M |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Verde Pink Sheet
If you are still planning to invest in Verde Bio Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Verde Bio's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |